{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:31:03Z","timestamp":1790101863116,"version":"4.0.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>In this study, we compared clinically relevant biochemical properties of each chelator for pH, osmolarity, and calcium chelation potential.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>In total, 0.2 M K<jats:sub>2<\/jats:sub>EDTA and K<jats:sub>3<\/jats:sub>EDTA (BD vacutainer tubes by Becton, Dickinson and Company) and Na<jats:sub>2<\/jats:sub>EDTA (Sigma Aldrich) solutions were made. The pH of each solution was measured (Mettler Toledo pH meter), and the theoretical osmolarity was calculated. Next, we determined the calcium chelation potential of each EDTA salt by titrating it with 10 \u03bcmol of calcium hydroxyapatite or CaCl<jats:sub>2<\/jats:sub> containing Patton\u2013Reeder colorimetric indicator. Statistical significance was analyzed using analysis of variance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The 0.2 M solutions of Na<jats:sub>2<\/jats:sub>EDTA, K<jats:sub>2<\/jats:sub>EDTA, and K<jats:sub>3<\/jats:sub>EDTA have pH values of 4.43, 5.71, and 9.191 and theoretical osmolarities of 600, 600, and 800 mOsm\/L, respectively. Calcium chelation ability was similar among all 3 solutions: 0.94 to 0.98 mol of EDTA was needed to fully chelate 1 mol calcium ions of CaCl<jats:sub>2<\/jats:sub> (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.296), 0.100 to 0.108 mol of EDTA for 1 mol calcium ions of the hydroxyapatite aqueous suspension (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.296), and 0.992 to 0.996 mol for 1 mol calcium ions of hydroxyapatite in acidic solution (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.178). Compared with the clinical standard of 3% (30 mg\/mL) Na<jats:sub>2<\/jats:sub>EDTA, approximately 3.3% (33 mg\/mL) K<jats:sub>2<\/jats:sub>EDTA and 3.6% (36 mg\/mL) K<jats:sub>3<\/jats:sub>EDTA are needed to chelate an equivalent amount of calcium.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In this article, we provide clinically relevant biochemical properties of 2 alternatives to Na<jats:sub>2<\/jats:sub>EDTA and demonstrate comparable calcium chelation ability among all 3 solutions. In situations where sterile sources of Na<jats:sub>2<\/jats:sub>EDTA are unavailable, potassium EDTA may provide a convenient and equally effective method of treatment for band keratopathy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ico.0000000000003370","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T15:03:27Z","timestamp":1692630207000},"page":"1551-1554","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Comparative Analysis of Alternative Calcium Chelators for the Treatment of Calcific Band Keratopathy"],"prefix":"10.1097","volume":"42","author":[{"given":"Zhuojun","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger K.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad H.","family":"Dastjerdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"key":"R2-20250728","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archopht.1952.00920010693002","article-title":"New treatment for calcific corneal opacities","volume":"48","author":"Grant","year":"1952","journal-title":"Arch Ophthalmol"},{"key":"R3-20250728","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/archopht.1954.00920050852005","article-title":"Chelation of calcium with edathamil calcium-disodium in band keratopathy and corneal calcium affections","volume":"52","author":"Breinin","year":"1954","journal-title":"Arch Ophthalmol"},{"key":"R4-20250728","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ajo.2004.01.036","article-title":"EDTA chelation for calcific band keratopathy: results and long-term follow-up","volume":"137","author":"Najjar","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R6-20250728","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/ICO.0000000000001558","article-title":"Off-the-Shelf K2-EDTA for calcific band keratopathy","volume":"37","author":"Lee","year":"2018","journal-title":"Cornea"},{"key":"R7-20250728","first-page":"645","article-title":"Transient band keratopathy associated with ocular inflammation and systemic hypercalcemia","volume":"2","author":"Galor","year":"2008","journal-title":"Clin Ophthalmol"},{"key":"R8-20250728","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/bjo.57.5.339","article-title":"Corneal and conjunctival calcification in chronic renal failure","volume":"57","author":"Porter","year":"1973","journal-title":"Br J Ophthalmol"},{"key":"R9-20250728","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12348-015-0062-z","article-title":"Uveitic band keratopathy: child and adult","volume":"5","author":"Nascimento","year":"2015","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"R10-20250728","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/ICU.0b013e3283477d36","article-title":"Corneal calcific band keratopathy","volume":"22","author":"Jhanji","year":"2011","journal-title":"Curr Opin Ophthalmol"},{"key":"R11-20250728","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ajo.2004.07.060","article-title":"EDTA chelation for calcific band keratopathy","volume":"139","author":"Arjamaa","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R12-20250728","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2147\/OPTH.S177636","article-title":"Removal of calcific band keratopathy without ethylenediaminetetraacetic acid (EDTA) in eyes with limited visual potential","volume":"12","author":"Bee","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"R13-20250728","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3341\/kjo.2010.24.2.73","article-title":"Combined ethylenediaminetetraacetic acid chelation, phototherapeutic keratectomy and amniotic membrane transplantation for treatment of band keratopathy","volume":"24","author":"Im","year":"2010","journal-title":"Korean J Ophthalmol"},{"key":"R14-20250728","doi-asserted-by":"crossref","first-page":"NP42","DOI":"10.1177\/1120672120969033","article-title":"Excimer laser-assisted phototherapeutic keratectomies combined to EDTA chelation for the treatment of calcific band keratopathy","volume":"32","author":"Spadea","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"R15-20250728","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3928\/1542-8877-19851001-12","article-title":"Surgical treatment of calcific band keratopathy","volume":"16","author":"Bokosky","year":"1985","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R16-20250728","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/eye.2017.264","article-title":"EDTA chelation for symptomatic band keratopathy: results and recurrence","volume":"32","author":"Al-Hity","year":"2018","journal-title":"Eye (Lond)"},{"key":"R17-20250728","first-page":"786","article-title":"A general statement of the laws of chemical equilibrium","volume":"99","author":"Le Chatelier","year":"1884","journal-title":"Comptes rendus"},{"key":"R18-20250728","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/ICO.0000000000002635","article-title":"Simplified, readily available method for the treatment of band keratopathy with ethylenediaminetetraacetic acid","volume":"40","author":"Narvaez","year":"2021","journal-title":"Cornea"},{"key":"R19-20250728","article-title":"Tri-potassium EDTA chelation for calcific band keratopathy: results and long-term follow-up","author":"DDibina BM","year":"2020"},{"key":"R20-20250728","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/jbm.a.33172","article-title":"Synthesis of calcium-silica composites: a route toward an in vitro model system for calcific band keratopathy precipitates","volume":"99A","author":"Doostdar","year":"2011","journal-title":"J Biomed Mater Res A"},{"key":"R21-20250728","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/cc2861","article-title":"Bench-to-bedside review: a brief history of clinical acid-base","volume":"8","author":"Story","year":"2004","journal-title":"Crit Care"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0000000000003370","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T22:02:14Z","timestamp":1753740134000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0000000000003370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0000000000003370","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,21]]},"assertion":[{"value":"2023-01-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}